175
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Lipopeptide-based liposomes for DNA delivery into cells expressing neuropilin-1

, , , , , , , , & show all
Pages 694-706 | Received 26 Jan 2006, Accepted 08 Aug 2006, Published online: 08 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Arehalli S. Manjappa, Peeyush N. Goel, Rajiv P. Gude & Rayasa S. Ramachandra Murthy. (2014) Anti-neuropilin 1 antibody Fab′ fragment conjugated liposomal docetaxel for active targeting of tumours. Journal of Drug Targeting 22:8, pages 698-711.
Read now
Dominique Briane, Hocine Slimani, Arezki Tagounits, Regine Naejus, Oualid Haddad, Robert Coudert, Nathalie Charnaux & An Cao. (2012) Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery. Journal of Drug Targeting 20:4, pages 347-354.
Read now
Chong Li, Jie Shen, Xiaoli Wei, Cao Xie & Weiyue Lu. (2012) Targeted delivery of a novel palmitylated D-peptide for antiglioblastoma molecular therapy. Journal of Drug Targeting 20:3, pages 264-271.
Read now

Articles from other publishers (18)

Lu Lu, Hongyuan Chen, Dake Hao, Xinke Zhang & Fengshan Wang. (2019) The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems. Asian Journal of Pharmaceutical Sciences 14:6, pages 595-608.
Crossref
Ziyao Kang, Qingbin Meng & Keliang Liu. (2019) Peptide-based gene delivery vectors. Journal of Materials Chemistry B 7:11, pages 1824-1841.
Crossref
Huan Wang, Xiaoyi Wang, Cao Xie, Mingfei Zhang, Huitong Ruan, Songli Wang, Kuan Jiang, Fei Wang, Changyou Zhan, Weiyue Lu & Hao Wang. (2018) Nanodisk-based glioma-targeted drug delivery enabled by a stable glycopeptide. Journal of Controlled Release 284, pages 26-38.
Crossref
Yujie Zhang, Yifei Lu, Yu Zhang, Xi He, Qinjun Chen, Lisha Liu, Xinli Chen, Chunhui Ruan, Tao Sun & Chen Jiang. (2017) Tumor-Targeting Micelles Based on Linear–Dendritic PEG–PTX 8 Conjugate for Triple Negative Breast Cancer Therapy . Molecular Pharmaceutics 14:10, pages 3409-3421.
Crossref
Ayelet David. (2017) Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment. Advanced Drug Delivery Reviews 119, pages 120-142.
Crossref
Hong-Jun Cho, Sung-Jin Lee, Sung-Jun Park, Chang H. Paik, Sang-Myung Lee, Sehoon Kim & Yoon-Sik Lee. (2016) Activatable iRGD-based peptide monolith: Targeting, internalization, and fluorescence activation for precise tumor imaging. Journal of Controlled Release 237, pages 177-184.
Crossref
Jingyan Cao, Ran Wang, Ning Gao, Minghui Li, Xuyu Tian, Weili Yang, Ying Ruan, Chunlan Zhou, Guangtian Wang, Xiaoying Liu, Shukun Tang, Yan Yu, Ying Liu, Guangyu Sun, Haisheng Peng & Qun Wang. (2015) A7RC peptide modified paclitaxel liposomes dually target breast cancer. Biomaterials Science 3:12, pages 1545-1554.
Crossref
V.A. Petrenko & P.K. Jayanna. (2014) Phage protein-targeted cancer nanomedicines. FEBS Letters 588:2, pages 341-349.
Crossref
Shivani Rai Paliwal, Rishi Paliwal, Govind P Agrawal & Suresh P Vyas. (2011) Liposomal nanomedicine for breast cancer therapy. Nanomedicine 6:6, pages 1085-1100.
Crossref
Helene Blois, Binrui Cao, Bryan Chin, Susan L Deutscher, Manuel Gea, Francois Iris, Prashanth Jayanna, Kimberley Kelly, Ramji Lakshmanan, Paul-Henri Lampe, Suiqiong Li, Lee Makowski, Karen Manoutcharian, Chuanbin Mao, Christopher J Noren, Stanley Opella, Flavie Pouillot, Steven Ripp & Lana SalehValery A. Petrenko & Prashanth K. Jayanna. 2011. Phage Nanobiotechnology. Phage Nanobiotechnology 55 82 .
Katarzyna A. Uniewicz, Michael J. Cross & David G. Fernig. (2011) Exogenous Recombinant Dimeric Neuropilin-1 Is Sufficient to Drive Angiogenesis. Journal of Biological Chemistry 286:1, pages 12-23.
Crossref
Dongdong Wu, Yanfeng Gao, Lixiang Chen, Yuanming Qi, Qiaozhen Kang, Haili Wang, Linyu Zhu, Yong Ye & Mingxia Zhai. (2010) Anti-tumor effects of a novel chimeric peptide on S180 and H22 xenografts bearing nude mice. Peptides 31:5, pages 850-864.
Crossref
C Nasarre, M Roth, L Jacob, L Roth, E Koncina, A Thien, G Labourdette, P Poulet, P Hubert, G Crémel, G Roussel, D Aunis & D Bagnard. (2010) Peptide-based interference of the transmembrane domain of neuropilin-1 inhibits glioma growth in vivo. Oncogene 29:16, pages 2381-2392.
Crossref
Prashanth K. Jayanna, Vladimir P. Torchilin & Valery A. Petrenko. (2009) Liposomes targeted by fusion phage proteins. Nanomedicine: Nanotechnology, Biology and Medicine 5:1, pages 83-89.
Crossref
Tarwadi, Jalal A. Jazayeri, Richard J. Prankerd & Colin W. Pouton. (2008) Preparation and in Vitro Evaluation of Novel Lipopeptide Transfection Agents for Efficient Gene Delivery. Bioconjugate Chemistry 19:4, pages 940-950.
Crossref
S. Cavalli & A. Kros. (2008) Scope and Applications of Amphiphilic Alkyl‐ and Lipopeptides. Advanced Materials 20:3, pages 627-631.
Crossref
Carla A. H. Prata, Xiao-Xiang Zhang, Dan Luo, Thomas J. McIntosh, Philippe Barthelemy & Mark W. Grinstaff. (2008) Lipophilic Peptides for Gene Delivery. Bioconjugate Chemistry 19:2, pages 418-420.
Crossref
Anna Starzec, Patrick Ladam, Roger Vassy, Sabah Badache, Nadia Bouchemal, Alda Navaza, Catherine Herv? du Penhoat & G?rard Y. Perret. (2007) Structure?function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF165 binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex. Peptides 28:12, pages 2397-2402.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.